Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

DNA copy number variation profiling and transcription profiling by array of 93 human lung squamous cell carcinoma samples

ABSTRACT: The basaloïd carcinoma (pure) and the basaloïd variant of lung squamous cell carcinoma (SCC) have a dismal prognosis but their underlying specific molecular characteristics remain obscure. This experiment uses DNA copy number aberrations and mRNA expression pangenomic profiles of 93 SCC, including 42 basaloïd samples (24 pure, 18 mixed) to reveal that pure basaloid tumors display a specific mRNA expression profile, encoding factors controlling the cell cycle, transcription, chromatin and splicing, with prevalent expression in germline and stem cells, while genes related to squamous differentiation are underexpressed. The related study demonstrates, for the first time, that basaloïd SCC constitute a distinct histo-molecular entity, which justifies its histologic recognition and distinction from SCC NOS. Additionally, their characteristic molecular profile highlights their intrinsic resistance to cytotoxic chemotherapy and could serve as a guide for targeted therapies.

ORGANISM(S): Homo sapiens

SUBMITTER: Fabien PETEL 

PROVIDER: E-MTAB-1727 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Lung squamous cell carcinomas with basaloid histology represent a specific molecular entity.

Brambilla Christian C   Laffaire Julien J   Lantuejoul Sylvie S   Moro-Sibilot Denis D   Mignotte Hélène H   Arbib François F   Toffart Anne-Claire AC   Petel Fabien F   Hainaut Pierre P   Rousseaux Sophie S   Khochbin Saadi S   de Reyniès Aurélien A   Brambilla Elisabeth E  

Clinical cancer research : an official journal of the American Association for Cancer Research 20140904 22

<h4>Purpose</h4>The basaloid carcinoma (pure) and the (mixed) basaloid variant of lung squamous cell carcinoma (SCC) have a dismal prognosis but their underlying specific molecular characteristics remain obscure and no therapy has proven to be efficient.<h4>Experimental design</h4>To assess their molecular specificity among other lung SCCs we analyzed DNA copy number aberrations and mRNA expression pangenomic profiles of 93 SCCs, including 42 basaloid samples (24 pure, 18 mixed).<h4>Results</h4>  ...[more]

Similar Datasets

Transcriptomics LSCC
2014-11-17 | E-MTAB-2435 | biostudies-arrayexpress
Transcriptomics Gene expression profiles of cervical cancers for novel molecular classification
2010-09-28 | GSE20167 | GEO
Transcriptomics Gene expression profiles of cervical cancers for novel molecular classification
2010-09-28 | E-GEOD-20167 | biostudies-arrayexpress
Transcriptomics Gene expression profiling of asbestos-related lung squamous cell carcinoma
2012-01-30 | GSE23822 | GEO
Transcriptomics The Role of JNK1/2 in Mouse Lung Squamous Cell Carcinoma (SCC) Development
2019-03-01 | GSE111314 | GEO
Transcriptomics EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer
2023-03-12 | GSE146975 | GEO
Transcriptomics SOX2 is a new oncogene activated by the recurrent 3q26.3 amplifications in lung Squamous Cell Carcinoma
2010-05-14 | E-GEOD-15080 | biostudies-arrayexpress
Transcriptomics ZNF750 is a lineage-specific tumor suppressor in squamous cell carcinoma [CaSki]
2016-08-25 | E-GEOD-86013 | biostudies-arrayexpress
Transcriptomics Gene expression profiling of asbestos-related lung squamous cell carcinoma
2012-01-30 | E-GEOD-23822 | biostudies-arrayexpress
Genomics Expression analysis of human pure squamous cell carcinoma of the bladder (Pure SCC) and muscle-invasive urothelial carcinoma without squamous differentiation (MIBC non-SD)
| PRJNA775612 | ENA